Bio Farma

Bio Farma, established in 1890, is a prominent entity within the Chemicals, Petrochemicals, Glass & Gases and Manufacturing sectors. Operating from two locations, the company has established itself as a leading vaccine manufacturer in Indonesia and Southeast Asia. Its core business revolves around life sciences, providing essential health services and products.

Annually, Bio Farma produces over 3.2 billion doses of vaccines, distributing them to more than 150 countries worldwide. The company generates a substantial revenue of $155.6M and employs a workforce ranging from 500 to 1,000 employees. This scale of operation is supported by a dedicated team, and details about their leadership can be found by visiting Meet Bio Farma's team. Their product portfolio includes vaccines, pharmaceuticals, and integrated health services, focusing on areas like immunization and cancer screening.

Bio Farma's commitment extends to ensuring the utmost safety, quality, and efficacy of its health products. This dedication is upheld through rigorous research initiatives and strict adherence to Good Manufacturing Practices (GMP). The company's intended clients primarily comprise healthcare providers and organizations actively engaged in public health initiatives, underscoring their role in global health security.